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Abstract
Background: Consumer genomic testing for nutrition and wellness, (nutritional 
genomics), is becoming increasingly popular. Concurrently, health- care practitioners 
(HPs) working in private practice (including doctors interested in integrative medicine, 
private genetic counsellors, pharmacists, dieticians, naturopaths and nutritionists) are 
involved as test facilitators or interpreters.
Objective: To explore Australian consumers’ and HPs’ experiences with nutrigenomic 
testing.
Method: Semi- structured in- depth interviews were conducted using predominantly 
purposive sampling. The two data sets were analysed individually, then combined, 
using a constant comparative, thematic approach.
Results: Overall, 45 interviews were conducted with consumers (n = 18) and 
HPs (n = 27). Many of the consumer interviewees experienced chronic ill- health. 
Nutrigenomic testing was perceived as empowering and a source of hope for 
answers. While most made changes to their diet/supplements post- test, self- 
reported health improvements were small. A positive relationship with their HP 
appeared to minimize disappointment. HPs’ adoption and views of nutrigenomic 
testing varied. Those enthusiastic about testing saw the possibilities it could offer. 
However, many felt nutrigenomic testing was not the only ‘tool’ to utilize when 
offering health care.
Discussion: This research highlights the important role HPs play in consumers’ expe-
riences of nutrigenomics. The varied practice suggests relevant HPs require upskilling 
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1  | INTRODUC TION
In recent years, personal genomic testing or ‘consumer genomics’ 
has placed genomic information into the hands of consumers. These 
tests promise risk predictions in diverse areas including fitness, re-
sponse to medications and traits such as premature balding. Also 
popular are tests for nutrition and wellness (nutrigenetic and nu-
trigenomic tests, hereafter referred to collectively as nutrigenomic 
tests), which offer diet and lifestyle recommendations that are per-
sonalized to genetic predisposition(s) to metabolic responses.1 Often 
advertised and sold online, these tests are marketed as being em-
powering and health transformative.2
Clinical validity (strength of the disease- gene relationship) and 
clinical utility (impact on health outcome) are essential when eval-
uating any genomic test. Current Australian guidelines recommend 
against the use of nutrigenomic testing unless the test, and related 
dietary interventions, are sufficiently evidence- based.3 Strong ev-
idence does exist for certain gene– nutrient relationships, as is the 
case for diets low in phenylalanine prescribed to people with phenyl-
ketonuria, a genetic disorder of amino acid metabolism.4 However, 
for commercially available nutrigenomic tests, many of the selected 
gene– nutrient interactions, and the associated dietary advice, lack 
sufficient evidence to be considered clinically valid and useful.5,6
Communicating the importance of clinical validity and utility be-
comes a challenge when genomic tests enter the consumer realm. An 
example of this is MTHFR gene testing.1,7 The MTHFR (methylenetet-
rahydrofolate reductase) gene is responsible for the production of 
an enzyme involved in folate metabolism. Many online sources im-
plicate two MTHFR single nucleotide polymorphisms (SNPs) in the 
risk of developing a myriad of health conditions and support the va-
lidity of testing and the utility of various supplements for prevention 
and treatment.8 However, a key international genetics organization9 
and prominent consumer genomics company 23andMe10 recom-
mend against MTHFR gene testing based on insufficient evidence. 
Nevertheless, clinical genetic services in Australian public hospitals 
have reported an increase in referrals for testing of MTHFR in recent 
years.11
Previously, genetic testing was reserved for diagnostic purposes 
in the context of inherited conditions and facilitated by genetic spe-
cialists or in primary care settings. Now, consumers can obtain nu-
trigenomic tests, including MTHFR gene tests, in a variety of other 
ways: some are available direct- to- consumer via online purchase 
and others via a ‘direct- to- practitioner’ model, where the process 
is facilitated by a health- care practitioner (HP), who may have been 
trained by the relevant testing company.12 A recent content analy-
sis of predominantly Australian websites revealed complementary/
alternative medicine (CAM) practitioners, including naturopaths and 
nutritionists, are offering to facilitate testing or provide support re-
garding results interpretation.2 Other HPs in private practice known 
to provide these services include general practitioners (GPs) with 
an interest in CAM (‘integrative’ GPs) and those working in allied 
health, such as dieticians, pharmacists and private genetic coun-
sellors (GCs).2 While GCs may not necessarily instigate this type of 
testing, in Australia there has been a substantial rise in consumer 
requests regarding consumer genomic testing, with 11% of genetic 
services reporting queries in 201113 increasing to 66% in 2017.14 
Additionally, in Australia, pharmacogenomic and nutrigenomic 
tests are sold by pharmacists over the counter in some community 
pharmacies.15
Published practice guidelines for GPs caution against the use of 
this testing,16 however, there is limited understanding of the practice 
of those in the fields of CAM and allied health.17 Further, little is 
known about consumer experiences of nutrigenomic tests, includ-
ing those for MTHFR. The Genioz (Genomics: National Insights of 
Australians) study sought to explore consumer views and, where ap-
propriate, experience with a variety of consumer genomic tests.18- 20 
Survey responses and follow- up interviews revealed that some 
Australians are interested in and are pursuing nutrigenomic testing, 
often via a CAM practitioner.19,20 These findings informed subse-
quent research to explore the landscape of HPs offering and/or in-
terpreting consumer genomic tests. This additional work was part 
of the Workforce and Education Program of Australian Genomics 
Health Alliance (Australian Genomics), which focusses on the work-
force implications of genomics in Australia.21 This paper presents 
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the combined findings of these interviews with both consumers and 
HPs to explore their experiences with nutrigenomics in Australia.
2  | METHODS
This study took a qualitative approach, comprising interview data 
from two data sets (Genioz to explore the experiences of the con-
sumers and Australian Genomics to explore HPs’ experiences). Ethics 
approval was obtained for both studies (HREC 1 545 806.3, Genioz 
project; and HREC 1 646 785.9, Australian Genomics). The Genioz 
project was overseen by an advisory group including representatives 
of patient/public groups who advised researchers on study design 
and assisted with recruitment.
2.1 | Participant recruitment
Consumers were purposively sampled from Genioz online survey re-
spondents (Figure 1).20 Survey respondents who indicated they would 
be prepared to be interviewed were sent an email. Given that survey 
respondents self- selected the type of test they had pursued, screen-
ing calls took place to confirm eligibility. It became apparent that many 
potential interviewees had pursued single gene testing for MTHFR 
only. Therefore, as recruitment and data collection continued, addi-
tional individuals who had undergone testing for this gene only were 
excluded to ensure all aspects of the data set were well captured.22
Specific HPs working in private practice were identified as those 
who do or could offer nutrigenomic testing (informed by findings of 
the Genioz study).20 CAM (naturopathy, nutrition, integrative medi-
cine) and allied health (dietetics, pharmacy and private genetic coun-
selling) practitioners were recruited via four methods: purposive 
sampling after an online search to identify key individuals; random 
sampling through advertisements placed in practitioner- specific 
professional society e- newsletters; convenience sampling through 
professional research networks; and snowballing sampling through 
interviewee networks. Invitation letters were emailed, to which in-
terested practitioners responded directly to the researcher.
2.2 | Data collection
Consumer interviews explored the participants’ motivations for pur-
suing testing, their recollection of pre- test information and receiving 
their results and any post- test behaviour changes (Supplementary 
1). Consumer interviews ranged in duration from 25- 75 minutes. 
Recruitment and data collection occurred iteratively between May 
2016 and December 2017. HP interviews sought to understand 
the landscape of practice regarding consumer genomics, includ-
ing nutrigenomics, awareness of this testing and its use in prac-
tice (Supplementary 2). HP interviews ranged in duration from 
15- 123 minutes. Recruitment and data collection occurred between 
February and December 2019.
2.3 | Data analysis
Audio recordings were transcribed verbatim and de- identified, with 
pseudonyms assigned to consumers and ID numbers assigned to 
HPs. NVivo 11 and NVivo 12 (QSR International, Melbourne, VIC, 
Australia) were used for data management, for consumers and HPs 
respectively.
For each data set, transcripts were coded by ET (consum-
ers) and CH (HPs) and analysed thematically, using an inductive, 
constant- comparative approach.23 A sample of the transcripts 
was coded independently by at least one other researcher for 
each data set (CH and SM for consumers; AR and SM for HPs), 
from which a consensus was reached regarding the final themes. 
Coding frameworks were developed for each data set with their 
own set of themes identified. Themes were then compared by ET, 
CH and SM, imported into a new NVivo 12 file and coded further, 
resulting in common themes presented in this paper and agreed 
upon by the other authors (additional consumer themes were 
published in a Genioz Honours research thesis, and additional 
HP themes are to be reported in a separate manuscript). Coding 
was also conducted regarding HPs’ views of and engagement with 
nutrigenomic testing in their practice. This resulted in a detailed 
matrix of the landscape of practice for all HPs, which was then 
visually represented as four quadrants. Four of the researchers 
(CH, BT, ET and SM) reached consensus with the placement of 
HPs in each specific quadrant based on each HP’s views of, and 




Eighteen consumers (Figure 1) and 28 HPs were interviewed 
(Figure 2). Participant characteristics are presented in Tables 1 and 
2, respectively. In the consumer cohort, HPs first suggested nutrig-
enomic testing to eight consumers, while 10 consumers initiated 
their own testing and sought advice post- test. While the HPs inter-
viewed in this study were cautious about nutrigenomic testing, their 
views of, and practice around, nutrigenomic testing varied, as shown 
in Figure 3. Their views ranged from being sceptical (‘testing sceptic’: 
left quadrants) to enthusiastic (‘testing enthusiast’: right quadrants). 
There was also a mix of engagement with testing provision: whether 
they adopted testing in their practice, including ordering a test and/
or interpreting test results (‘clinical adoption’: top quadrants), or re-
ported little or no engagement (‘no adoption’: bottom quadrants). 
For example:
The DNA test, it actually zones in a little bit more … I 
send them off to the chemist to get them…it made me 
go, oh great, I’ve got science answering my question. 
(Nutritionist 4, right top quadrant)
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I get a lot of email requests saying, ‘I heard you’re in 
this space and I want a genetic test to do X, Y and 
Z’ and I have to say, ‘that’s not something I can help 
you with’ and it’s also hard, you’ve got to be careful 
with your wording, saying, ‘I don’t recommend that’ 
without actually having seen them, but you can just 
tell from the email that a lot of it is not an evidence- 
based test yet… if people already have results then I 
have seen them to be able to help them understand 
what it means to them in the context of their health 
F I G U R E  1   Consumer recruitment
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goal and whether there’s any useable information in 
there or not. 
(Dietician 1, left top quadrant)
I don’t really feel like it really fits into my practice cur-
rently. That’s not to say it won’t in the future…if they 
[client] brought that in I would have no problem with 
that. I wouldn’t dismiss it as being invalid or not of any 
use but I would then look at the company that has 
carried out the testing and go from there… 
(Naturopath 1, right bottom quadrant)
My personal and professional opinion would probably 
be I don’t know why someone would want to do that 
[nutrigenomic testing] of their own accord… 
(Pharmacist 1, left bottom quadrant)
3.2 | Themes
Three key themes were developed from the two data sets. Illustrative 
quotes are included in- text, with additional quotes in Table 3.
3.2.1 | Theme 1 – Nutrigenomics: offering a 
source of hope?
Thirteen of the consumer participants had a long history of 
health problems and were yet to find any answers or solutions 
to provide a diagnosis or to guide future treatment and manage-
ment of their condition, as shown in Table 3: Quote 1 and also 
described below:
And I’ve seen so many different doctors and I’ve done 
the standard tests, you know, just the standard blood 
tests a million times, only to get the same sort of re-
sponse from my doctors that I was all good, it was all 
fine. 
(Lucy)
Some consumers were unsure what to expect from nutrigenomic 
testing and described ‘taking a leap of faith’ that testing would pro-
vide not only answers but tangible solutions to their health concerns 
(Table 3: Quote 2).
Several consumers first came across nutrigenomic testing while 
searching online and explained that they did not do much research 
into the nutrigenomic testing company, or the specific test, before 
undertaking testing. Allison said: 'I didn't really look that much into 
[nutrigenomic testing]. I just wanted my profile done so I could find out 
how to treat MTHFR.'
Despite their own eagerness to pursue nutrigenomic testing, 
several consumers were discouraged from testing by their conven-
tional HPs (Table 3: Quote 3) and reported that CAM practitioners 
appeared more willing to use nutrigenomic testing. The HP inter-
viewees had varied views on what nutrigenomics could offer their 
patients/clients. Some expressed similar excitement as the con-
sumers regarding the possibilities of this testing (Table 3: Quote 
4). Some described instances in which they believed testing was 
useful:
I had a guy who was overweight…we got talking about 
this test and so he did the test and he came back and 
we did his results and one of his results was…to do 
with letting the brain know that you’ve eaten enough 
food…I think it was helpful for him. 
(Pharmacist 2)
F I G U R E  2   Health- care practitioner recruitment
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TA B L E  2   Health- care practitioner characteristics
Health- care 
practitioner type
Range of years of 
practice
Have had a consumer test for 
self
Tertiary training in 
genetics Training in nutrition
Naturopath n = 6 Recently 
graduated- >20 years
Yes: n = 2
No: n = 3
Not stated: n = 1
No: n = 4
Yes: n = 2 (basics)
Yes: n = 6
Nutritionist n = 4 7- 16 years Yes: n = 1
Not stated: n = 1
No: n = 2
No: n = 2
Yes: n = 2 (basics)
Yes: n = 4
Integrative general 
practitioner n = 4
13- >30 years Yes: n = 1
No: n = 3 (1 offered but 
declined)
No: n = 2
Yes: n = 2 (basics)
No: n = 2




counsellor n = 6
7- 25 years No: n = 5
Yes: n = 1
Yes: n = 6 Yes: n = 1
No: n = 5
Dietician n = 3 5- 13 years Yes: n = 1
No: n = 1
Not stated: n = 1
No: n = 3 Yes: n = 3
Pharmacist n = 4 3- 15 years No: n = 1
Not stated: n = 3
No: n = 1
Yes: n = 2 (basics)
Not stated: n = 1
No: n = 4
F I G U R E  3   Visual representation of the variability between HPs in their practice of nutrigenomics. Clinical adoption: from testing and 
interpretation (top) to referring (in between) to no adoption where this testing does not fit into a practitioner's current practice (bottom). 
Each HP was coded as enthusiastic, sceptical or in between according to their views on testing. The same process was conducted for HP 
engagement with testing.
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Whereas other HPs spoke of the limitations of testing (Table 3: 
Quote 5) and the importance of understanding the patient's broader 
health circumstances:
I think that there is a lot of interesting stuff you can 
glean from a genetic test as long as you are really 
aware of the limitations of that test and you know 
how to put it in the context of the patient in front of 
you…unless you actually understand a whole heap 
about the patient you can’t do anything really useful 
with that… 
(Private GC1)
Health- care practitioners also acknowledged their clients’ quest 
for answers, noting that nutrigenomic testing was often the last option 
to be explored:
They’re asking you to fix [them]. The guy that brought 
that [DNA testing] he’s got chronic fatigue symptoms, 
heavy metal poisoning and… was basically saying, ‘is 
there anything in there that’s stopping me getting 
better?’ Which he has done every test under the sun, 
the genetic test was the last one. 
(Nutritionist 3)
While consumers described nutrigenomic testing as a last resort 
and a final hope for answers, many wished they could have accessed 
testing much earlier to reduce emotional impact. They also hoped to 
avoid the trial- and- error they reported experiencing and which they 
felt was associated with conventional medical practice and standard 
CAM:
I wish I had known about this stuff a bit sooner be-
cause I have been absolutely put through the ringer 
by a lot of medical people. Even stuff to the point 
where it’s like, ‘Is this all in your mind?’ 
(Samira)
3.2.2 | Theme 2 – The varying practice and 
expectations of nutrigenomics in health care
Several consumers reported previous negative experiences with 
GPs and specialists during their health- care journey, which influ-
enced their perception of nutrigenomics. Many consumers actively 
sought out an HP who could facilitate testing or help interpret re-
sults. Beth explained:
The professor was discouraging me from [nutrige-
nomic testing]… I said, ‘I just want to do it because it 
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These consumers saw an interest in nutrigenomics as a sign an HP 
may provide them with the care/support they desired. Other consum-
ers explained that their CAM practitioner recommended nutrigenomic 
testing, including MTHFR gene testing, and they commented that they 
were happy to have testing with the specific company suggested by 
the HP (Table 3: Quote 6). Several consumers explained that their HP 
had had testing themselves, which increased their confidence in both 
the test and information they received (Table 3: Quote 7). Consumers 
reported limited pre- test counselling, however and justified this by 
stating they had an existing relationship and trust in their health- care 
practitioner:
I don’t know that he went into full- on detail be-
cause…I’ve been seeing him, I’ve known him for a few 
years so he sort of, he didn’t have to explain it - you 
know what I mean? …I have a good relationship with 
him so I trust his judgement on that. 
(Natasha)
Angela and Bridget reported that, following the results of their 
first nutrigenomic testing, they were advised by their HP to purchase 
additional tests, including for ancestry. This was, as Angela explained, 
to gain ‘more information’. Several consumers reported that they were 
advised to download their raw genomic data from ancestry genomic 
testing and use it to obtain health information from online third- party 
interpretation programmes (Table 3: Quote 8). A few HPs had also 
mentioned helping consumers with third- party interpretation reports 
(Table 3: Quote 9).
A few HPs, particularly, private GCs, felt testing did not fit within 
their practice and would advise clients to go elsewhere (Table 3: 
Quote 10). However, many had adopted nutrigenomics in their prac-
tice in some way: actively ordering testing or encouraging clients to 
order nutrigenomic testing online and bring the results back for in-
terpretation (Table 3: Quote 11). Not all HPs felt they were equipped 
to talk to their patients/clients about nutrigenomic tests:
I’ll tell them to go back to the person who ordered the 
test because I don’t understand this, that my knowl-
edge is limited and it wasn’t me who initiated the test 
and then to go back to the service who organised this 
because they will have a better idea. 
(Integrative GP 1)
Nevertheless, many HPs in this cohort were willing to have a con-
versation with their patients/clients and some felt it important not to 
dismiss the testing outright (Table 3: Quote 12), while a few practi-
tioners questioned whether nutrigenomic testing has a place in their 
discipline (Table 3: Quote 13). Additionally, private GCs agreed nutrig-
enomic testing does not have a place in public genetic clinics:
I think Genetics [the profession] has been a bit lax 
in having a voice in this field…I do see GCs dismiss it 
too quickly and I think that they are, in dismissing the 
client, leave that client open to alternative therapists 
that are much less educated. 
(Private GC 1)
Some HPs have found this testing useful and explained that ini-
tially they were actively ordering and encouraging testing. Yet, as 
time has passed, they have found they now only turn to it for specific 
circumstances:
I'm using genetic testing less and less. If you’d asked 
me a couple of years ago, I would’ve been like, 
‘Everyone gets a 23andMe’…Now I only do it if we’re 
really looking for something in particular…I found that 
it wasn’t necessarily changing my course of action. 
It was justifying the course of action, but it wasn’t 
changing the course of action. 
(Naturopath 4)
Despite an awareness that nutrigenomic testing may offer hope 
to their clients, in practice HPs in this cohort said they would not al-
ways offer nutrigenomic testing in the first instance. HPs described 
nutrigenomic testing as one tool of many that they can utilize and not 
necessarily the first, or only, tool they would use:
There are certain practitioners in Australia, naturo-
pathic practitioners, where their business revolves 
around genetics. In fact…I saw someone yesterday 
who had previously been seeing one of those practi-
tioners, so they had all that information but for them 
that had gone a bit too far, it was just all about genet-
ics and for them that was a bit of a negative now…
It provides a few pieces of a bigger puzzle, it doesn’t 
give the answers. 
(Naturopath 3)
Beyond ordering testing and/or results interpretation, HPs also 
spoke of their role in managing patient/client expectations. They ex-
plained that without understanding the limitations of nutrigenomic 
testing, consumers may expect to receive all the answers they are 
looking for:
Another major factor is you’ve got to also think about 
the patients’ expectations, what is the question the 
patient is wanting answered… patients will say ‘I want 
to know what food I can and can’t eat’ and it doesn’t 
matter how accurate a genetic test is sometimes in 
regards to the nutrigenetics variation, they’re never 
going to answer that question. 
(Dietician 1)
A few HPs felt they were ‘picking up the pieces’ after consumers 
had had testing elsewhere (Table 3: Quote 14) and then came to them 
for help:
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I think if the person themselves initiated because 
they’ve got some rationale in their own mind, and 
wanted to discuss it with me, I’d be happy to dis-
cuss the pros and cons with them…I’m finding myself 
largely in the position of the person who kind of like 
helping them to pick up the pieces of what that means 
in their life. 
(Integrative GP 2)
3.2.3 | Theme 3 – Balancing clinical and 
personal utility
Many HPs described the tension between supporting patients and 
questioning the clinical validity and utility of the testing and the 
trustworthiness of the testing companies (Table 3: Quotes 15- 16). 
This could place some HPs in an ethically challenging situation:
I actually feel a little bit apprehensive about it be-
cause I don’t know that I can see the validity within 
my own practice, or a little bit about the ethics does 
concern me too, I don’t really feel like it really fits into 
my practice currently. 
(Naturopath 1)
MTHFR gene testing posed the most challenges for the HP inter-
viewees. While some were very confident in the validity and utility of 
MTHFR testing (Table 3: Quote 17), others were wary (Table 3: Quotes 
18- 19). Several HPs spoke of balancing their clients’ enthusiasm with 
MTHFR testing with an acknowledgement of its limitations and spoke 
of using other methods of investigation instead:
If someone comes to you and they’ve got a problem 
with – they’ve got anxiety or they’ve got this and that 
…’I think I want an MTHFR’ … you just go, ‘All right. So, 
you’ve got MTHFR but what does that mean? So, what 
that means is, for me, I would then run a check on 
their histamine and homocysteine and look for mark-
ers of methylation to tell me which B vitamins, which 
folate, which B12, et cetera to give the person. 
(Naturopath 4)
Despite these varying views of HPs on the usefulness of nutrig-
enomics, most of the consumer interviewees relayed positive expe-
riences with testing and MTHFR testing was reported as providing 
the answer for which many participants had been searching (Table 3: 
Quote 20). Receiving nutrigenomic test results was not only perceived 
to be empowering but consumers believed the results confirmed that 
their illness was not ‘psychosomatic’, despite what they had been told 
by their conventional HPs. Lucy said: 'To finally have someone acknowl-
edge that and say, you know, ‘You're not crazy, there is actually something 
going on’… It's hard to put words to it, how big of a meaning that had for 
me.'
As a result of their testing, some consumers reported making 
minor changes to their diets and others changed their supplement 
regimens. However, despite the perception that nutrigenomic test-
ing gave them answers (Table 3: Quote 21), self- reported improve-
ments to health were limited for most. Some used the term ‘trial and 
error’ to describe the process of finding the right combination and 
doses of supplements to take. Allison explained: 'It's been a very hard 
process… all the trial and error, and the wasted money and the wasted 
time…'
Others found the information provided with the nutrigenomic 
testing results relatively unhelpful:
So…it suggested be careful with caffeine and alcohol 
and stuff …, what does that mean? Does that mean 
I shouldn’t, be drinking, full stop…Is that something 
that would just show up on everyone’s report, be-
cause good health advice is don’t drink too much…
It’s hard to interpret …from a reasonable lifestyle 
perspective. 
(Connor)
Nevertheless, all consumers remained positive about their decision 
to pursue nutrigenomic testing and valued the fact that they had found 
an HP who was not only willing to work with their nutrigenomic result 
but also validated their health concerns. Thus, it appears that nutrig-
enomic testing had personal utility even in the absence of actionable 
results.
4  | DISCUSSION
Nutrigenomic testing has grown in popularity in Australia, with inter-
est from consumers and HPs. This may in part be due to the posi-
tively framed marketing that has circulated online.24 It appears that 
these online marketing strategies, portraying nutrigenomic testing 
as ‘health transformative’2 particularly resonate with people who are 
chronically unwell and those with an interest in CAM.
Most consumers in our study reported their health as being 
‘poor’ or ‘fair’ and described themselves as being chronically unwell. 
Unlike early adopters of consumer genomic testing, who were pri-
marily motivated by curiosity and an interest in the science,25 the 
chronically unwell consumers in this study saw nutrigenomic test-
ing as a ‘means to an end’, having tried everything else and finding 
no answers to their health concerns. This is consistent with a pre-
vious characterization of CAM users.26 While nutrigenomic testing 
was not as health- transformative as the consumer participants had 
hoped, they remained positive about their decision to pursue test-
ing. The majority of consumers reported feeling empowered and 
validated after receiving their nutrigenomic testing results. This 
was particularly true for those who discovered they had a particular 
MTHFR SNP that they felt could explain their health concerns.
Early qualitative research exploring patient and doctor ex-
periences of diagnosing MTHFR polymorphisms and providing 
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treatments noted the vast array of self- reported, unvalidated in-
formation online.27 In one study from the USA, patients reported 
the frustration of seeing many doctors throughout their lives and 
receiving no relief to their chronic symptoms and the majority de-
scribed receiving their MTHFR test results as validating, empower-
ing and life- changing.27 Likewise, some of the chronically unwell 
consumers in our study perceived MTHFR SNPs to be the diagnosis 
for which they were searching. After receiving feedback from ‘main-
stream’ HPs that nothing could be done for them, when participants 
received nutrigenomic testing results, they perceived it as providing 
tangible ‘solutions’ to their health concerns. Many reported little 
health improvements that could be explained as a direct result of 
nutrigenomic testing interventions, however, and the recommen-
dations provided were often not the easy solutions that they had 
expected. Further, when considering the price of the test (ranging 
from AU$99 to more than AUD$500), the out- of- pocket fee for a 
consultation with a CAM provider or private GC, plus the costs of 
potential supplements, nutrigenomic testing can become a costly 
endeavour and may not be accessible to consumers with lower 
socio- economic status.
Despite feeling disappointed, the chronically unwell consumers 
in this study maintained a positive attitude towards nutrigenomic 
testing. They reported benefit from the knowledge they gleaned 
from testing. There are varied published views regarding clinical and 
personal utility of genomic testing. Bunnik, Janssens and Schermer 
28 state personal utility does not exist when there is no evidence 
of clinical utility. Conversely, Kohler, Turbitt and Biesecker 29 con-
ducted a systematic review of ‘personal utility’ of genomic infor-
mation (generally), finding that the information in itself is perceived 
as valuable, and has personal usefulness, to consumers. Other 
beneficial outcomes included enhanced self- knowledge, feelings 
of control over the situation and the future, improved coping and 
well- being and the fulfilment of curiosity about what the results 
may reveal.29 Thus, while nutrigenomic testing still led to ‘trial and 
error’ treatments in our cohort, results can provide consumers with 
a perception of knowledge and a sense of relief, hope and validation. 
However, the general population may not derive the same perceived 
benefits from nutrigenomic testing and may instead be at risk of 
disappointment.
The trusting relationship the consumers had with their HP who 
was involved with the nutrigenomic test (or test results) also miti-
gated disappointment with the test outcomes. Much of the positive 
experience of nutrigenomic testing therefore came from finding an 
HP who was willing to listen and did not immediately discount their 
chronic symptoms. This has been similarly described in the area of 
homeopathy.30 Given this, it is possible that the positive response to 
nutrigenomic testing relates less to nutritional genomic science and 
more to psychosocial factors including receiving support, empathy 
and validation from their HP. Having an HP who supports nutrige-
nomic testing, and has even had testing themselves, can add a sense 
of legitimacy to the test which may influence clients accordingly. HP- 
facilitated testing is also one way of mitigating the possibility that 
consumers will misinterpret their test results. However, the range 
of disciplines and the varied nature of practice between HPs could 
prove problematic for consumers in choosing an HP. Additionally, 
concerns remain that HPs may be inadequately trained to facilitate 
informed decision making.31,32 Given that some nutrigenomic test-
ing companies train the HPs in- house,19 this represents a potential 
conflict of interest and could translate to consumers receiving biased 
information and advice based on poor evidence.
A key tenet of genetic counselling, now a regulated profession in 
Australasia,33 is facilitating clients’ long- term adaptation to genomic 
information.34 Genetic counsellors have traditionally been employed 
in hospitals within a public health system, counselling patients for 
tests ordered via an accredited laboratory. Scepticism regarding va-
lidity and utility of nutrigenomic testing, accompanied by GCs’ per-
ception that commercial consumer genomic tests may not belong in 
the public health genetic clinic, is a valid concern. However, more re-
cently, GCs are working in private practice33 and/or in collaboration 
with a variety of HPs outside of traditional genetic clinics. Private 
GCs are well placed to facilitate adaptation to nutrigenomic test re-
sults and provide the information and support that the consumers in 
our study desired.
Most GPs and allied health practitioners have limited knowledge 
of nutrigenomics and many also question the validity of testing.35,36 
Thus, consumers, as our cohort illustrated, have been turning to 
CAM, including integrative medicine, practitioners. It can be difficult 
for HPs to make sense of nutrigenomic results and indeed consumer 
genomic testing in general for patients.37- 39 This research revealed 
discrepancies between consumers’ expectations of when to have a 
nutrigenomic test and when an HP might deem it appropriate. HPs 
also spoke of the need to mediate patient/client expectations and 
discuss the limitations of testing. When consumers are advertised to 
directly, limitations of testing are not generally highlighted.2
Many of the consumer interviewees experienced chronic illness 
and felt that a nutrigenomic test from the outset would have been 
preferable to their protracted and frustrating health- care experience 
to date. However, it is also of note that despite many publications in 
just under the last two decades, there is still concern in the nutrig-
enomics field that the gap between experiments and evidence for 
health practice has not yet been achieved.39 More evidence- based 
resources, summaries and recommendations for HPs to use have 
been advocated.39 Additionally, depending on their profession, HPs 
have many different tools to call upon when faced with supporting 
a client/patient. Some are unique to each discipline; however, most 
of the HPs in this study felt that nutrigenomic testing was the final 
tool to call upon.
Despite its contested evidence base, nutrigenomic testing is 
available to the public. There are clearly gaps between the expecta-
tions of consumers and the realities of what tools HPs may utilize to 
help find the underlying cause of a health issue. While the HPs in this 
cohort spoke of limitations and some discouraged testing, consumer 
data demonstrate that individuals may instead seek out a new HP 
who would facilitate testing. HPs’ support of and experience with 
nutrigenomic testing may also influence clients’ willingness to un-
dergo testing.
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4.1 | Limitations
The majority of eligible consumers responded to the invitation for 
recruitment, however, given the nature of this process, it is likely 
not all types of experiences of personal genomics were captured in 
this cohort. Most consumer participants were relieved to discover an 
MTHFR polymorphism, but others who had a more negative experi-
ence may not have responded to the survey. Access to nutrigenomic 
testing may also vary based on ethnicity and socio- economic status. 
Consumers in our study identified as primarily Australian (presum-
ably Caucasian – noting that they could select more than one ethnic 
ancestry in the survey), highly educated, and resided in areas of mid-
dle to high socio- economic advantage. While this is consistent with 
previous characterizations of CAM users,26 the views of individuals 
who are interested in this testing, but unable to afford it or for whom 
it may not be suitable due to poor ethnic coverage of reference data 
in some tests, may not have been captured.
While a broad number of different types of HPs were inter-
viewed, few who currently actively order and promote nutrigenomic 
testing in their daily practice responded to an invitation to partic-
ipate. Additionally, as each data set was collected at two different 
time points it may not reflect the landscape of HPs’ practice at 
the time of consumer interviews as highlighted by Naturopath 4 in 
Theme 2. Nevertheless, the findings provide a unique insight into 
both consumer and HP experiences of nutrigenomic testing.
5  | CONCLUSION
This study provides insights into the motivations and experiences of 
consumers undertaking nutrigenomic testing and a snapshot of the 
landscape of practice and attitudes of a range of HPs in Australia. In 
particular, consumers with chronic ill- health are motivated to have 
testing and make dietary/supplement changes post- test. More re-
search is needed to determine the extent to which these changes 
persist long- term. Further, this research highlights the important 
role that HPs facilitating nutrigenomic testing play in the experience 
of test- takers, while also emphasising the variability of practice and 
enthusiasm of testing across HPs and within each discipline. It is rec-
ommended that HPs who are likely to be approached by their pa-
tients/clients about nutrigenomics should increase their awareness 
of this testing to enable conversations and facilitate informed deci-
sion making, even if it is not part of their practice. Future research 
could explore the training currently available to HPs and any support 
or education they may require.
Currently, Australian guidelines and key international genetics 
organizations caution against the broad use of nutrigenomic tests. 
Nevertheless, our market society, paired with a strong rhetoric of 
consumer empowerment, has meant that individuals are accessing 
this type of testing. Further, the consumer participants in this study 
reported positive experiences with nutrigenomic testing despite the 
scientific community cautioning its use. Ultimately, it is imperative 
that appropriate and balanced information and support is available 
to those interested in nutrigenomic testing to ensure informed de-
cisions are made. How such resources and supports are made avail-
able, however, is a greater challenge.
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